Summary
CVS Health Corp (CVS) filed an 8-K on September 15, 2004, reporting on a significant debt offering. The company successfully issued $650 million in 4% Notes due 2009 and $550 million in 4 7/8% Notes due 2014. These notes were issued in a private offering exempt from registration requirements. The primary purpose of this debt issuance was to finance the recent acquisition of approximately 1,260 Eckerd drugstores and Eckerd's pharmacy benefits management and mail order businesses. This strategic move significantly expands CVS's retail footprint, particularly in the southern United States, and integrates substantial pharmacy benefit operations.
Key Highlights
- 1CVS Corporation issued $1.2 billion in aggregate principal amount of new debt: $650 million of 4% Notes due 2009 and $550 million of 4 7/8% Notes due 2014.
- 2The debt was issued via a private offering exempt from the Securities Act of 1933.
- 3Proceeds from the offering were used to repay commercial paper that financed the acquisition of ~1,260 Eckerd drugstores.
- 4The acquisition also included Eckerd Health Services, encompassing pharmacy benefits management and mail order operations.
- 5The new notes are general unsecured obligations of the company.
- 6CVS has the option to redeem the notes under specific conditions, including a premium based on Treasury Yield plus a spread.
- 7The transaction was reported on September 15, 2004, with the event date of the earliest reported event being September 14, 2004.